Early research (Phase 1)Study completedNCT02462954What this trial is testingA Safety Study Of The Caya® Diaphragm Used With ContraGel®Who this might be right forContraception CONRAD 23
Not applicableStudy completedNCT03205657What this trial is testingAuto/Allo Tandem Transplant for Relapsed B-NHLWho this might be right forNon Hodgkin Lymphoma New York Medical College 12
Not applicableLooking for participantsNCT06894810What this trial is testingInvestigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer SurvivorsWho this might be right forUnmet Fertility Information Needs Murdoch Childrens Research Institute 358
Early research (Phase 1)WithdrawnNCT04500548What this trial is testingTesting the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI StudyWho this might be right forConstitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07043894What this trial is testingRomiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer PatientsWho this might be right forSolid TumorsHematological TumorChildren+2 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Not applicableLooking for participantsNCT07632014What this trial is testingCAYA Cancer Prospective Cohort StudyWho this might be right forCancerPediatric CancerLymphoblastic Lymphoma (LBL)+1 more Resonance, Inc. 6,000
Large-scale testing (Phase 3)Looking for participantsNCT06563245What this trial is testingBrentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT AssessmentWho this might be right forClassical Hodgkin LymphomaChildAdolescent+6 more Children's Cancer Group, China 96
Not applicableLooking for participantsNCT06621810What this trial is testingArtificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young AdultsWho this might be right forMelanoma (Skin Cancer)Artificial Intelligence (AI)Pediatric Cancer German Cancer Research Center 3,000
Testing effectiveness (Phase 2)WithdrawnNCT00801918What this trial is testingDenileukine Diftitox for Relapsed ALCLWho this might be right forAnaplastic Large-Cell Lymphoma Columbia University
Not applicableLooking for participantsNCT06692868What this trial is testingFertility Protection for Children, Adolescents and Young AdultsWho this might be right forStem Cell TransplantStem Cell TransplantationOncological Outcomes+8 more University of Ulm 2,000
Not applicableLooking for participantsNCT06519682What this trial is testingA Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)Who this might be right forHigh Grade GliomaReplication Repair Deficient Daniel Morgenstern 20
Not applicableLooking for participantsNCT07246213What this trial is testingCAYA Cancer Retrospective Cohort StudyWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic LymphomaYoung Adult Cancer+4 more Resonance, Inc. 18,000
Not applicableUnknownNCT06281912What this trial is testingImpact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma PatientsWho this might be right forEarly MelanomaAdvanced Melanoma Azienda Ospedaliera di Perugia 70
Early research (Phase 1)Looking for participantsNCT04972942What this trial is testingTargeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaWho this might be right forT-cell Acute Lymphoblastic LeukemiaT-Cell Acute Lymphoblastic Lymphoma New York Medical College 30
Testing effectiveness (Phase 2)Study completedNCT01842672What this trial is testingMitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoblastic Lymphoma+2 more New York Medical College 41